Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application

by Tom A. Mulder, Björn E. Wahlin, Anders Österborg, Marzia Palma
Published 2019-06-01

BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects

by Marzia Palma, Marzia Palma, Tom A. Mulder, Anders Österborg, Anders Österborg
Published 2021-07-01

Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia

by Tom A. Mulder, Lucía Peña-Pérez, Anna Berglöf, Stephan Meinke, H. Yesid Estupiñán, Kia Heimersson, Rula Zain, Robert Månsson, C. I. Edvard Smith, Marzia Palma
Published 2021-05-01

Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients

by Glenn F. Van Wigcheren, Nienke De Haas, Tom A. Mulder, Sophie K. Horrevorts, Martine Bloemendal, Simone Hins-Debree, Yumeng Mao, Rolf Kiessling, Carla M.L. van Herpen, Georgina Flórez-Grau, Stanleyson V. Hato, I. Jolanda M. De Vries
Published 2021-01-01